CK Life Sciences Files Patent Applications for Circular mRNA TROP2 Cancer Vaccine
- Written by Reporters
Breast Cancer Animal Studies Show Unprecedented Anti-Cancer Efficacy of 100% Tumor Growth Inhibition
HONG KONG SAR - Media OutReach Newswire - 11 April 2025 - CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences"), a leader in cancer vaccine development, announces the latest progress in its pharmaceutical R&D, namely the filing of an...Read more: CK Life Sciences Files Patent Applications for Circular mRNA TROP2 Cancer Vaccine

